SABRA HEALTH CARE REIT INC (SBRA) Stock Fundamental Analysis

NASDAQ:SBRA • US78573L1061

20.55 USD
-0.31 (-1.49%)
At close: Feb 27, 2026
20.55 USD
0 (0%)
After Hours: 2/27/2026, 8:00:02 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

4

SBRA gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 122 industry peers in the Diversified REITs industry. SBRA has a medium profitability rating, but doesn't score so well on its financial health evaluation. SBRA is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

  • In the past year SBRA was profitable.
  • SBRA had a positive operating cash flow in the past year.
  • The reported net income has been mixed in the past 5 years: SBRA reported negative net income in multiple years.
  • In the past 5 years SBRA always reported a positive cash flow from operatings.
SBRA Yearly Net Income VS EBIT VS OCF VS FCFSBRA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M -200M

1.2 Ratios

  • SBRA has a better Return On Assets (2.83%) than 71.31% of its industry peers.
  • SBRA has a better Return On Equity (5.51%) than 67.21% of its industry peers.
  • With a decent Return On Invested Capital value of 3.88%, SBRA is doing good in the industry, outperforming 71.31% of the companies in the same industry.
  • The Average Return On Invested Capital over the past 3 years for SBRA is in line with the industry average of 3.08%.
  • The 3 year average ROIC (3.71%) for SBRA is below the current ROIC(3.88%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 2.83%
ROE 5.51%
ROIC 3.88%
ROA(3y)1.83%
ROA(5y)0.45%
ROE(3y)3.54%
ROE(5y)0.95%
ROIC(3y)3.71%
ROIC(5y)3.47%
SBRA Yearly ROA, ROE, ROICSBRA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2 -2 4 6 8

1.3 Margins

  • With a decent Profit Margin value of 20.09%, SBRA is doing good in the industry, outperforming 69.67% of the companies in the same industry.
  • SBRA's Profit Margin has declined in the last couple of years.
  • Looking at the Operating Margin, with a value of 34.06%, SBRA is in the better half of the industry, outperforming 69.67% of the companies in the same industry.
  • SBRA's Operating Margin has declined in the last couple of years.
  • SBRA has a Gross Margin of 66.87%. This is comparable to the rest of the industry: SBRA outperforms 47.54% of its industry peers.
  • In the last couple of years the Gross Margin of SBRA has declined.
Industry RankSector Rank
OM 34.06%
PM (TTM) 20.09%
GM 66.87%
OM growth 3Y-3.2%
OM growth 5Y-4.77%
PM growth 3YN/A
PM growth 5Y-2.77%
GM growth 3Y-4.64%
GM growth 5Y-4.04%
SBRA Yearly Profit, Operating, Gross MarginsSBRA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 40 60 80

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), SBRA is destroying value.
  • The number of shares outstanding for SBRA has been increased compared to 1 year ago.
  • Compared to 5 years ago, SBRA has more shares outstanding
  • The debt/assets ratio for SBRA is higher compared to a year ago.
SBRA Yearly Shares OutstandingSBRA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M 250M
SBRA Yearly Total Debt VS Total AssetsSBRA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

2.2 Solvency

  • Based on the Altman-Z score of 0.97, we must say that SBRA is in the distress zone and has some risk of bankruptcy.
  • SBRA's Altman-Z score of 0.97 is fine compared to the rest of the industry. SBRA outperforms 70.49% of its industry peers.
  • SBRA has a Debt/Equity ratio of 0.90. This is a neutral value indicating SBRA is somewhat dependend on debt financing.
  • SBRA has a Debt to Equity ratio of 0.90. This is in the better half of the industry: SBRA outperforms 64.75% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.9
Debt/FCF N/A
Altman-Z 0.97
ROIC/WACC0.56
WACC6.96%
SBRA Yearly LT Debt VS Equity VS FCFSBRA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B 2B 3B

2.3 Liquidity

  • A Current Ratio of 1.48 indicates that SBRA should not have too much problems paying its short term obligations.
  • SBRA's Current ratio of 1.48 is fine compared to the rest of the industry. SBRA outperforms 74.59% of its industry peers.
  • A Quick Ratio of 1.48 indicates that SBRA should not have too much problems paying its short term obligations.
  • The Quick ratio of SBRA (1.48) is better than 76.23% of its industry peers.
Industry RankSector Rank
Current Ratio 1.48
Quick Ratio 1.48
SBRA Yearly Current Assets VS Current LiabilitesSBRA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 20.75% over the past year.
  • SBRA shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -0.91% yearly.
  • The Revenue has grown by 10.15% in the past year. This is quite good.
  • Measured over the past years, SBRA shows a small growth in Revenue. The Revenue has been growing by 5.29% on average per year.
EPS 1Y (TTM)20.75%
EPS 3YN/A
EPS 5Y-0.91%
EPS Q2Q%-42.11%
Revenue 1Y (TTM)10.15%
Revenue growth 3Y7.43%
Revenue growth 5Y5.29%
Sales Q2Q%16.21%

3.2 Future

  • The Earnings Per Share is expected to grow by 11.73% on average over the next years. This is quite good.
  • The Revenue is expected to grow by 11.91% on average over the next years. This is quite good.
EPS Next Y20.21%
EPS Next 2Y11.73%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year5.71%
Revenue Next 2Y4.92%
Revenue Next 3Y8.54%
Revenue Next 5Y11.91%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
SBRA Yearly Revenue VS EstimatesSBRA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 200M 400M 600M 800M 1B
SBRA Yearly EPS VS EstimatesSBRA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.5 -0.5 1 1.5

More info and screens

Find the best growth stocksShow best growing peers

2

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 32.11, which means the current valuation is very expensive for SBRA.
  • The rest of the industry has a similar Price/Earnings ratio as SBRA.
  • Compared to an average S&P500 Price/Earnings ratio of 27.10, SBRA is valued at the same level.
  • A Price/Forward Earnings ratio of 26.71 indicates a quite expensive valuation of SBRA.
  • Based on the Price/Forward Earnings ratio, SBRA is valued cheaper than 84.43% of the companies in the same industry.
  • When comparing the Price/Forward Earnings ratio of SBRA to the average of the S&P500 Index (28.06), we can say SBRA is valued inline with the index average.
Industry RankSector Rank
PE 32.11
Fwd PE 26.71
SBRA Price Earnings VS Forward Price EarningsSBRA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

  • SBRA's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. SBRA is more expensive than 60.66% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 16.99
SBRA Per share dataSBRA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8 10

4.3 Compensation for Growth

  • The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
PEG (NY)1.59
PEG (5Y)N/A
EPS Next 2Y11.73%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

5

5. Dividend

5.1 Amount

  • SBRA has a Yearly Dividend Yield of 5.75%, which is a nice return.
  • SBRA's Dividend Yield is a higher than the industry average which is at 6.76.
  • Compared to an average S&P500 Dividend Yield of 1.80, SBRA pays a better dividend.
Industry RankSector Rank
Dividend Yield 5.75%

5.2 History

  • The dividend of SBRA decreases each year by -2.44%.
  • SBRA has paid a dividend for at least 10 years, which is a reliable track record.
  • SBRA has decreased its dividend recently.
Dividend Growth(5Y)-2.44%
Div Incr Years0
Div Non Decr Years1
SBRA Yearly Dividends per shareSBRA Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5

5.3 Sustainability

  • 186.04% of the earnings are spent on dividend by SBRA. This is not a sustainable payout ratio.
DP186.04%
EPS Next 2Y11.73%
EPS Next 3YN/A
SBRA Yearly Income VS Free CF VS DividendSBRA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M -200M
SBRA Dividend Payout.SBRA Dividend Payout, showing the Payout Ratio.SBRA Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

SABRA HEALTH CARE REIT INC

NASDAQ:SBRA (2/27/2026, 8:00:02 PM)

After market: 20.55 0 (0%)

20.55

-0.31 (-1.49%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)02-12
Earnings (Next)05-04
Inst Owners98.72%
Inst Owner Change6.74%
Ins Owners1%
Ins Owner Change7.06%
Market Cap5.12B
Revenue(TTM)774.63M
Net Income(TTM)155.61M
Analysts76
Price Target21.97 (6.91%)
Short Float %9.01%
Short Ratio7.85
Dividend
Industry RankSector Rank
Dividend Yield 5.75%
Yearly Dividend1.18
Dividend Growth(5Y)-2.44%
DP186.04%
Div Incr Years0
Div Non Decr Years1
Ex-Date02-13
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-44.68%
Min EPS beat(2)-51.75%
Max EPS beat(2)-37.61%
EPS beat(4)1
Avg EPS beat(4)-10.49%
Min EPS beat(4)-51.75%
Max EPS beat(4)51.26%
EPS beat(8)2
Avg EPS beat(8)-12.84%
EPS beat(12)2
Avg EPS beat(12)-37.62%
EPS beat(16)3
Avg EPS beat(16)-70.46%
Revenue beat(2)1
Avg Revenue beat(2)6.1%
Min Revenue beat(2)-0.25%
Max Revenue beat(2)12.46%
Revenue beat(4)3
Avg Revenue beat(4)3.96%
Min Revenue beat(4)-0.25%
Max Revenue beat(4)12.46%
Revenue beat(8)7
Avg Revenue beat(8)2.98%
Revenue beat(12)8
Avg Revenue beat(12)2%
Revenue beat(16)10
Avg Revenue beat(16)1.09%
PT rev (1m)0.74%
PT rev (3m)1.2%
EPS NQ rev (1m)-2.2%
EPS NQ rev (3m)-7.29%
EPS NY rev (1m)-1.68%
EPS NY rev (3m)-4.12%
Revenue NQ rev (1m)0.39%
Revenue NQ rev (3m)-3.85%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-4.51%
Valuation
Industry RankSector Rank
PE 32.11
Fwd PE 26.71
P/S 6.61
P/FCF N/A
P/OCF 14.7
P/B 1.82
P/tB 1.86
EV/EBITDA 16.99
EPS(TTM)0.64
EY3.11%
EPS(NY)0.77
Fwd EY3.74%
FCF(TTM)-0.42
FCFYN/A
OCF(TTM)1.4
OCFY6.8%
SpS3.11
BVpS11.32
TBVpS11.05
PEG (NY)1.59
PEG (5Y)N/A
Graham Number12.77
Profitability
Industry RankSector Rank
ROA 2.83%
ROE 5.51%
ROCE 4.91%
ROIC 3.88%
ROICexc 3.93%
ROICexgc 3.98%
OM 34.06%
PM (TTM) 20.09%
GM 66.87%
FCFM N/A
ROA(3y)1.83%
ROA(5y)0.45%
ROE(3y)3.54%
ROE(5y)0.95%
ROIC(3y)3.71%
ROIC(5y)3.47%
ROICexc(3y)3.75%
ROICexc(5y)3.51%
ROICexgc(3y)3.78%
ROICexgc(5y)3.54%
ROCE(3y)4.7%
ROCE(5y)4.39%
ROICexgc growth 3Y5.81%
ROICexgc growth 5Y1.97%
ROICexc growth 3Y5.63%
ROICexc growth 5Y2.01%
OM growth 3Y-3.2%
OM growth 5Y-4.77%
PM growth 3YN/A
PM growth 5Y-2.77%
GM growth 3Y-4.64%
GM growth 5Y-4.04%
F-Score5
Asset Turnover0.14
Health
Industry RankSector Rank
Debt/Equity 0.9
Debt/FCF N/A
Debt/EBITDA 5.61
Cap/Depr 242.22%
Cap/Sales 58.47%
Interest Coverage 2.38
Cash Conversion 77.32%
Profit Quality N/A
Current Ratio 1.48
Quick Ratio 1.48
Altman-Z 0.97
F-Score5
WACC6.96%
ROIC/WACC0.56
Cap/Depr(3y)121.85%
Cap/Depr(5y)94.04%
Cap/Sales(3y)30%
Cap/Sales(5y)24.45%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)20.75%
EPS 3YN/A
EPS 5Y-0.91%
EPS Q2Q%-42.11%
EPS Next Y20.21%
EPS Next 2Y11.73%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)10.15%
Revenue growth 3Y7.43%
Revenue growth 5Y5.29%
Sales Q2Q%16.21%
Revenue Next Year5.71%
Revenue Next 2Y4.92%
Revenue Next 3Y8.54%
Revenue Next 5Y11.91%
EBIT growth 1Y2.66%
EBIT growth 3Y4%
EBIT growth 5Y0.26%
EBIT Next Year84.49%
EBIT Next 3Y23.17%
EBIT Next 5YN/A
FCF growth 1Y-159.92%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y12.26%
OCF growth 3Y3.36%
OCF growth 5Y-0.36%

SABRA HEALTH CARE REIT INC / SBRA FAQ

What is the ChartMill fundamental rating of SABRA HEALTH CARE REIT INC (SBRA) stock?

ChartMill assigns a fundamental rating of 4 / 10 to SBRA.


Can you provide the valuation status for SABRA HEALTH CARE REIT INC?

ChartMill assigns a valuation rating of 2 / 10 to SABRA HEALTH CARE REIT INC (SBRA). This can be considered as Overvalued.


How profitable is SABRA HEALTH CARE REIT INC (SBRA) stock?

SABRA HEALTH CARE REIT INC (SBRA) has a profitability rating of 5 / 10.


Can you provide the expected EPS growth for SBRA stock?

The Earnings per Share (EPS) of SABRA HEALTH CARE REIT INC (SBRA) is expected to grow by 20.21% in the next year.


How sustainable is the dividend of SABRA HEALTH CARE REIT INC (SBRA) stock?

The dividend rating of SABRA HEALTH CARE REIT INC (SBRA) is 5 / 10 and the dividend payout ratio is 186.04%.